Truist Financial
TXG icon

Truist Financial’s 10x Genomics TXG Stock Holding History

Truist Financial’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,846
Closed -$222K – 2632
2024
Q3 		$222K Sell
9,846
-617
-6% -$12.8K ﹤0.01% 2294
2024
Q2 		$204K Sell
10,463
-804
-7% -$21.1K ﹤0.01% 2496
2024
Q1 		$423K Buy
+11,267
New +$495K ﹤0.01% 2072
2022
Q1 		– Sell
-1,436
Closed -$214K – 2851
2021
Q4 		$214K Buy
+1,436
New +$220K ﹤0.01% 2553

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Truist Financial's TXG Position: Q4 2024 in Review

Truist Financial sold out of 10x Genomics (TXG) in Q4 2024, closing a stake of 9,846 shares — an estimated $222K sold.

Truist Financial first reported a position in TXG in Q4 2021 and held it in 4 quarters. The position peaked at $423K in Q1 2024. 273 funds tracked by Wall St. Rank hold TXG as of Q4 2024.

  • Truist Financial reported no remaining 10x Genomics position as of Q4 2024 after selling out during the quarter.
  • Truist Financial sold 9,846 10x Genomics shares in Q4 2024, an estimated $222K.
  • Truist Financial first reported a position in 10x Genomics in Q4 2021 and held it in 4 quarters.
  • Truist Financial's 10x Genomics position peaked at $423K in Q1 2024.
  • 273 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2024.

Based on Truist Financial's 13F filing for Q4 2024, filed 31 Jan 2025.